677304-64-2

Basic information

• Product Name: 6-methoxybenzo[d]isothiazole-3-carboxylic acid
• Synonyms: 6-methoxybenzo[d]isothiazole-3-carboxylic acid
• CAS NO: 677304-64-2
• Molecular Formula: C₉H₇NO₃S
• Molecular Weight: 209.224
• Mol File: 677304-64-2.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-methoxybenzo[d]isothiazole-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 6-methoxybenzo[d]isothiazole-3-carboxylic acid(677304-64-2)
• EPA Substance Registry System: 6-methoxybenzo[d]isothiazole-3-carboxylic acid(677304-64-2)

Safety Data

• Hazardous Substances Data: 677304-64-2(Hazardous Substances Data)

Usage

General Description

6-methoxybenzo[d]isothiazole-3-carboxylic acid is a chemical compound with the molecular formula C9H7NO4S. It is a heterocyclic compound containing a benzene ring fused to an isothiazole ring with a carboxylic acid group attached at the 3-position. 6-methoxybenzo[d]isothiazole-3-carboxylic acid is often used in organic synthesis and medicinal chemistry as a building block for the synthesis of various pharmaceuticals and biologically active compounds. It has been studied for its potential anti-inflammatory and anti-cancer properties, and its structure and reactivity make it a versatile starting material for the production of new compounds with therapeutic potential.

Upstream product

• 932702-34-6 ethyl 6-methoxy-benzo[d]isothiazole-3-carboxylate 
• 677304-74-4 6-methoxy-benzo[d]isothiazole-3-carboxylic acid amide 
• 67-56-1 methanol 
• 19532-55-9 6-methoxybenzisothiazol-3(2H)-one 

Relevant articles and documents

Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

NICOTINIC ALPHA-7 RECEPTOR LIGANDS AND PREPARATION AND USES THEREOF

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, AND 1,2-BENZISOTHIAZOLES, AND PREPARATION AND USES THEREOF

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds for example, indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.